Immunopathology & Immunotherapy

Am J Gastroenterol 2013; 108:1620–1630; doi:10.1038/ajg.2013.257; published online 24 September 2013

Sieglinde Angelberger MD1, Walter Reinisch MD1, Athanasios Makristathis PhD2, Cornelia Lichtenberger1, Clemens Dejaco MD1, Pavol Papay MD1, Gottfried Novacek MD1, Michael Trauner MD1, Alexander Loy PhD3 and David Berry PhD3

Divulgative resumen: http://medicalxpress.com/news/2013-09-microbial-inflamed-gut.html

Including Immunology (pathology and therapies) topics:

• 29 TYpE 2 DiAbETES MElliTUS | A central role of the gut in glucose homeostasis; Geltrude Mingrone and Lidia Castagneto-Gissey
• 30 METAbOliSM | The gut microbiota manages host metabolism; Patrice D. Cani
• 35 hEpATiTiS C | HCV causes systemic disorders that can be cured; Francesco Negro
• 37 fAECAl MiCRObiOTA TRANSplANTATiON | Developing human gut microbiota as a class of therapeutics; Alexander Khoruts
• 38 COEliAC DiSEASE | New insights in dietary-gluten-induced autoimmunity; Katri Kaukinen and Markku Mäki
• 42 ibD | Enriching the therapeutic armamentarium for IBD;  Silvio Danese and Laurent Peyrin-Biroulet
• 51 TRANSplANTATiON iMMUNOlOgY | New approaches to diagnosis of rejection; Nicholas A. Zwang and Laurence A. Turka
• 65 MUlTiplE SClEROSiS | Novel triggers, treatment targets and brain atrophy measures; Xavier Montalban and Mar Tintoré
• 71 SYSTEMiC lUpUS ERYThEMATOSUS | Taking a closer look at biologic therapy for SLE; David A. Isenberg and Anisur Rahman
• 72 EpigENETiCS | DNA methylation and miRNA—key roles in systemic autoimmunity; Bruce C. Richardson and Dipak R. Patel
• 74 RhEUMATOiD ARThRiTiS | Translational medicine in RA—time for change; Pierre Miossec